tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Technical Analysis

Compare
444 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Sell
1Bullish
5Neutral
4Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Spyre Therapeutics’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is -1.73, suggesting Spyre Therapeutics is a Sell.
Spyre Therapeutics’s (SYRE) 20-Day exponential moving average is 14.37, while Spyre Therapeutics’s (SYRE) share price is $13.57, making it a Sell.
Spyre Therapeutics’s (SYRE) 50-Day exponential moving average is 17.31, while Spyre Therapeutics’s (SYRE) share price is $13.57, making it a Sell.

Spyre Therapeutics (SYRE) Pivot Points

Apr 22, 2025, 11:48 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.68
11.36
11.89
12.57
13.10
13.78
14.31
Fibonacci
11.36
11.82
12.11
12.57
13.03
13.32
13.78
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Apr 22, 2025, 11:48 AM
Period
Simple
Exponential
MA5
12.61Buy
12.64Buy
MA10
12.53Buy
13.08Sell
MA20
14.71Sell
14.37Sell
MA50
18.05Sell
17.31Sell
MA100
21.09Sell
20.52Sell
MA200
25.26Sell
24.48Sell
Spyre Therapeutics’s (SYRE) 10-Day exponential moving average is 13.08, while Spyre Therapeutics’s (SYRE) share price is $13.57, making it a Sell.
Spyre Therapeutics’s (SYRE) 100-Day exponential moving average is 20.52, while Spyre Therapeutics’s (SYRE) share price is $13.57, making it a Sell.
Spyre Therapeutics’s (SYRE) stock price is $13.57 and Spyre Therapeutics’s (SYRE) 50-day simple moving average is 18.05, creating a Sell signal.
Spyre Therapeutics’s (SYRE) stock price is $13.57 and Spyre Therapeutics’s (SYRE) 100-day simple moving average is 21.09, creating a Sell signal.
Spyre Therapeutics’s (SYRE) stock price is $13.57 and Spyre Therapeutics’s (SYRE) 200-day simple moving average is 25.26, creating a Sell signal.

Spyre Therapeutics (SYRE) Technical Indicators

Apr 22, 2025, 11:48 AM
Name
Value
Implied Action
RSI (14)
36.17
Neutral
STOCH (9,6)
52.84
Neutral
STOCHRSI (14)
23.65
Neutral
MACD (12,26)
-1.73
Sell
ADX (14)
52.65
Sell
Williams %R
-73.98
Buy
CCI (14)
-64.51
Neutral
ATR (14)
1.35
-
Ultimate Oscillator
48.71
Neutral
ROC
-29.38
Sell
Spyre Therapeutics’s (SYRE) Relative Strength Index (RSI) is 36.17, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Trend Strength Indicator (ADX) is 52.65, creating a Sell signal.
Spyre Therapeutics’s (SYRE) Commodity Channel Index (CCI) is -64.51, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Price Rate of Change (ROC) is -29.38, creating a Sell signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Sell.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 36.17, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is -1.73, which suggests SYRE is a Sell.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 12.61, which suggests SYRE is a Buy.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 14.71, which suggests SYRE is a Sell.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 18.05, which suggests SYRE is a Sell.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 25.26, which suggests SYRE is a Sell.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -73.98, which suggests SYRE is a Buy.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is -64.51, which suggests SYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis